相关实验视频
Updated: Jul 4, 2025

06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
9.5K
初级胆道胆道炎的治疗方法:超出了ursodeoxycholic酸的范围
M C van Hooff1, E Werner1, A J van der Meer1
1Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Doctor Molewaterplein 40, NA building, Floor 6, Rotterdam 3015 GD, the Netherlands.
European journal of internal medicine
|February 2, 2024
概括
初级胆道胆道炎 (PBC) 管理需要对患者进行风险分层,这些患者对 Ursodeoxycholic 酸 (UDCA) 反应不佳. 新疗法和更严格的目标改善了肝病进展风险的人的结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 初级胆道胆炎 (PBC) 是一种罕见的免疫媒介性肝病,可变的进展到肝硬化和相关并发症.
- 乌尔苏多氧胆酸 (UDCA) 是一线治疗,改善了代孕标志物和无移植生存率,但许多患者仍在进展.
- 风险分层对于确定需要超出UDCA的额外治疗的患者至关重要.
研究的目的:
- 审查对PBCUDCA治疗的当前见解.
- 讨论基于残留风险的强化治疗的患者选择.
- 总结PBC中二线治疗选择的疗效.
主要方法:
- 关于PBC治疗和结果的最新文献的审查.
- 基于多因素的风险分层策略的分析.
- 对二线治疗的随机对照试验的评估.
主要成果:
- UDCA提供了生存效益,但残留风险需要进一步管理.
- 更严格的生化目标可能可以通过附加疗法实现.
- 法尔内索伊德X受体激动剂,PPAR激动剂和皮质类固醇在特定患者中显示出有前途.
结论:
- 个性化风险分层是管理PBC的关键.
- 用二线药物优化治疗反应可以改善临床结果.
- 不断变化的治疗环境为在PBC中实现更好的患者结果提供了更多选择.
更多相关视频
相关概念视频
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Peptic Ulcer Disease IV: Management
93
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Acute Pancreatitis II: Clinical Manifestations and Management
125
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
125

